Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Femoral vs Adductor Canal Blocks in TKA
NCT02453321Phase 4Completed
- Start
- Jun 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (3 arms). Primary endpoint: Time to Achieve Physical Therapy Discharge Criteria as Measured by 75-feet Walk Test. Started Jun 2015; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02453321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02453321.